Ideas
Gold set for substantial further upside.
Gold has plenty more upside driven by expected dollar weakness over the next 12 months, its role as a classic inflationary hedge, concerns about sovereign debt-to-GDP ratios making it an attractive quasi-currency, and continued central bank buying (89% of central banks surveyed plan to increase gold allocation). Dips are viewed as buying opportunities. BNP Paribas has a 12-month gold target of $5,000.
Long AUD as dollar diversification play.
The Australian dollar is an attractive way to diversify away from the US dollar, benefiting from a higher carry and expected moderate dollar weakness of about 3.5% over the next 12 months.
Yen to strengthen on BOJ rate hikes.
The yen's underlying trends have turned more positive. After intervention, the outlook depends on fundamentals, and the Bank of Japan is likely to hike rates in October with potentially two more hikes next year, supporting further yen strength.
Buy semiconductor dip on AI pullback.
Semiconductor stocks are a multi-year AI story. The recent pullback has created more interesting and much better priced entry levels compared to where they were, although the segment remains volatile. Investors with the ability to tolerate risk can use the dip to buy.
Rotate into Japanese equities.
Japanese equities are an attractive rotation destination for investors who are over-concentrated in AI and semiconductor stocks, as part of a broader strategy to rotate into other geographies.
Buy industrials as AI beneficiaries.
Industrials are a safer, easier way to play the AI theme indirectly, as they are beneficiaries of the AI buildout without the high volatility of direct AI semiconductor stocks.
Buy infrastructure as AI beneficiaries.
Infrastructure is another safer indirect play on the AI theme, benefiting from the same trends while being less volatile than direct AI chip stocks.
PB Fintech poised for strong earnings growth.
PB Fintech is seeing sustained high growth of around 35% for the next three to four years, driven by low insurance penetration in India and a large addressable market. Margins are set to expand as the renewal mix grows to over 50% of the book, renewals carry 35% margins, and the company is the dominant distributor with a long runway in health and life insurance.
Manipal Health undervalued post-IPO.
Manipal Health offers value at 29x earnings after its IPO, as a large portion of proceeds will pay down debt, making the company net debt zero. The company has a strong presence in three significant Indian markets, a successful acquisition integration track record, and plans for expansion into Mumbai and central India, supported by strong cash generation.
This Bloomberg Markets video, published August 06, 2026,
features Shafali Sachdev, Yashish Dahiya, Karthik Rajagopal
discussing GLD, AUD/USD, FXY, SMH, BTC, XLI, PAVE, PB Fintech, Manipal Health Enterprises.
9 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Shafali Sachdev,
Yashish Dahiya,
Karthik Rajagopal
· Tickers:
GLD,
AUD/USD,
FXY,
SMH,
BTC,
XLI,
PAVE,
PB Fintech,
Manipal Health Enterprises